A new approach to personalized treatment for obesity
A NOVEL PRECISION MEDICINE APPROACH FOR OBESITY: A RANDOMIZED, MULTI-CENTER TRIAL
This study is looking to help people with obesity lose weight more effectively by figuring out which factors influence how well anti-obesity medications work for them, so they can create personalized weight-loss plans just for you!
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Phenomix Sciences, LLC NIH-funded |
| Lab location | 1 site (Menlo Park, UNITED STATES) |
| Project ID | NIH-11056890 on NIH RePORTER |
What this research studies
This research investigates how to improve weight loss outcomes for individuals with obesity by identifying predictors of response to anti-obesity medications (AOMs). The study will involve a randomized, multi-center trial that aims to develop individualized weight-loss strategies based on patient characteristics. By phenotyping participants, the research seeks to understand the variability in weight loss responses and enhance the effectiveness of treatments. Patients will be monitored for their weight loss progress and any side effects from the medications.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are struggling with obesity and seeking effective weight loss solutions.
Not a fit: Patients who are not overweight or obese, or those who do not meet the age criteria, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized obesity treatments, improving weight loss outcomes for patients.
How similar studies have performed: Other research has shown promise in identifying predictors of response to obesity treatments, suggesting that this approach could yield significant insights.
Where this research is happening
Menlo Park, UNITED STATES
- Phenomix Sciences, LLC — Menlo Park, United States (Active)
Researchers
- Principal investigator: Bagnall, Mark — Phenomix Sciences, LLC
- Study coordinator: Bagnall, Mark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.